Induction of MASH in three-dimensional bioprinted human liver tissue.
Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (MASH), is a major risk factor for cirrhosis and hepatocellular carcinoma (HCC) and a leading cause of liver transplantation. MASH is caused by an accumulation of toxic fat molecules in the hepato...
Saved in:
| Main Authors: | Vaidehi Joshi, Dwayne Carter, Alice E Chen, Keith Murphy, J William Higgins, Mediha Gurel, Daisy Chilin Fuentes, Sara Brin Rosenthal, Kathleen M Fisch, Tatiana Kisseleva, David A Brenner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0312615 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Induction of MASH-like pathogenesis in the Nwd1 −/− mouse liver
by: Seiya Yamada, et al.
Published: (2025-03-01) -
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study
by: Manuel Castro Cabezas, et al.
Published: (2025-05-01) -
Naringenin attenuates early hepatocarcinogenesis induced by a MASH model
by: Linda Vanessa Márquez-Quiroga, et al.
Published: (2025-07-01) -
Resmetirom: The First Disease-Specific Treatment for MASH
by: Ali Mohamed Mousa, et al.
Published: (2025-01-01) -
Pharmacotherapeutic perspectives on nutraceuticals in the treatment of MASLD and MASH
by: Ali H. Eid, et al.
Published: (2025-05-01)